Profund Advisors LLC
- SEC CIK
- 0001129919
- Latest filing
- Aug 11, 2026
KROS holding history
Keros Therapeutics, Inc. in every 13F filed by Profund Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KROS overviewAll 13F holders of KROSFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −11,483−100.0% | Sold out | Holders |
| Q4 2025 | 11,483 | $233.8K | <0.1% | +11,483 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −11,421−100.0% | Sold out | Holders |
| Q2 2025 | 11,421 | $152.5K | <0.1% | −148−1.3% | Reduced | Holders |
| Q1 2025 | 11,569 | $117.9K | <0.1% | +11,569 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −8,392−100.0% | Sold out | Holders |
| Q3 2024 | 8,392 | $487.3K | <0.1% | −2,415−22.3% | Reduced | Holders |
| Q2 2024 | 10,807 | $493.9K | <0.1% | −7,854−42.1% | Reduced | Holders |
| Q1 2024 | 18,661 | $1.24M | <0.1% | +7,814+72.0% | Added | Holders |
| Q4 2023 | 10,847 | $431.3K | <0.1% | +826+8.2% | Added | Holders |
| Q3 2023 | 10,021 | $319.5K | <0.1% | −2,914−22.5% | Reduced | Holders |
| Q2 2023 | 12,935 | $519.7K | <0.1% | +1,091+9.2% | Added | Holders |
| Q1 2023 | 11,844 | $505.7K | <0.1% | +11,844 | New | Holders |